Summary
- Current Price
- As of today, LSB price is $0.63, with unknown change on
- Current Price All-Time High
- LSB price is currently at its all-time high
- Market Cap
- LSB current market cap is $26M, with unknown 1-year change
- PE Ratio
- LSB PE ratio is unknown
- Revenue
- LSB current annual revenue is $85.67M, up +6.00% year-over-year
- Next Earnings
- As of today, the next earnings release for LSB has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | LakeShore Biopharma Co., Ltd |
| Ticker | NASDAQ: LSB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | China |
| IPO | |
| Indexes | Not included |
| Website | ysbiopharm.com |
| Employees | 758 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.63 | ||
| Price, 1D Change | - | |
| $26M | ||
| - | ||
| - | ||
| - | ||
| $86M | ||
| Revenue, 1Y Change | +6.00% | |
| -$0.73 | ||
| EPS, 1Y Change | -28.07% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | YS | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.73 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $85.67M | ||
| Revenue Estimate | N/A | $1.45B |
| Revenue Est. Change | N/A | +1,591.81% |
| $0.63 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.46 | -$0.57 | -23.91% | |
| - | -$0.73 | - | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $83.50M | $80.82M | -3.21% | |
| - | $85.67M | - | |
| $1.45B | N/A | +1,591.81% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +6.00% | ||
| - | ||
| -28.07% | ||
| -100.00% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.63 | ||
| $0.63 | ||
| SMA 200 vs Price | 0.00% | |
| $0.63 | ||
| SMA 50 vs Price | 0.00% | |
| - | ||
| $0.04 | ||
| 0.00 | ||
| - | ||
| - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $85.67M | ||
| -$0.73 | ||
| $70.66M | ||
| 82.48% | ||
| -$6.91M | ||
| -8.06% | ||
| -$13.93M | ||
| -16.26% | ||
| -$1.80M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.83 | ||
| 1.02 | ||
| 0.74 | ||
| - | ||
| - | ||
| -1.99 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 0.60 | ||
| 0.31 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $69.62M | ||
| $14.97M | ||
| $190.53M | ||
| $117.33M | ||
| $118.65M | ||
| $114.90M | ||
| $57.73M | ||
| $54.46M | ||
| $6.90M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $99.60M | ||
| $77.56M | ||
| $15.01M | ||
| $0.00 | ||
| $5.11M | ||
| $0.00 | ||
| -$131.90K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$16.85M | ||
| -$2.37M | ||
| -$498.90K | ||
| $2.49M | ||
| -$19.34M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| No data | N/A | N/A |
Analyst sentiment
Institutional ownership
Screeners with LSB
FAQ
What is the ticker symbol for LakeShore Biopharma Co., Ltd?
The ticker symbol for LakeShore Biopharma Co., Ltd is NASDAQ:LSB
Does LakeShore Biopharma Co., Ltd pay dividends?
No, LakeShore Biopharma Co., Ltd does not pay dividends
What sector is LakeShore Biopharma Co., Ltd in?
LakeShore Biopharma Co., Ltd is in the Healthcare sector
What industry is LakeShore Biopharma Co., Ltd in?
LakeShore Biopharma Co., Ltd is in the Biotechnology industry
What country is LakeShore Biopharma Co., Ltd based in?
LakeShore Biopharma Co., Ltd is headquartered in China
When did LakeShore Biopharma Co., Ltd go public?
LakeShore Biopharma Co., Ltd initial public offering (IPO) was on August 5, 2021
Is LakeShore Biopharma Co., Ltd in the S&P 500?
No, LakeShore Biopharma Co., Ltd is not included in the S&P 500 index
Is LakeShore Biopharma Co., Ltd in the NASDAQ 100?
No, LakeShore Biopharma Co., Ltd is not included in the NASDAQ 100 index
Is LakeShore Biopharma Co., Ltd in the Dow Jones?
No, LakeShore Biopharma Co., Ltd is not included in the Dow Jones index
When was LakeShore Biopharma Co., Ltd last earnings report?
LakeShore Biopharma Co., Ltd's most recent earnings report was on December 19, 2025
When does LakeShore Biopharma Co., Ltd report earnings?
The date for LakeShore Biopharma Co., Ltd's next earnings report has not been announced yet
Data Sources & References
- LSB Official Website www.ysbiopharm.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1946399/000121390024069344/0001213900-24-069344-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1946399/000121390025069880/0001213900-25-069880-index.htm
- LSB Profile on Yahoo Finance finance.yahoo.com/quote/LSB
- LSB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lsb